Supply chain resilience has moved into the deal room

The EU Critical Medicines Act is accelerating a shift in how life sciences organisations assess risk, value and opportunity. Supply chain resilience is no longer just an operational concern. It is increasingly shaping due diligence, valuation and strategic decision-making
Data as a Product: Why “more data” hasn’t meant better decisions

Many organisations have more data than ever before, yet still struggle to make informed decisions. The difference often isn’t technology or data quality, but clear ownership, accountability and governance.
Pharma M&A in 2026: Buying the platform, not the molecule

Pharma M&A has always been driven by a mix of factors. What’s increasingly shaping how deals get structured now is a newer consideration: owning the platform behind a deal, not just the asset itself.
Restructuring in Life Sciences: What the headcount numbers don’t tell you

Restructuring headlines focus on headcount and cost savings. What they rarely capture is the operational capability and institutional knowledge lost along the way – a cost that doesn’t show up until months later, and one life sciences organisations can ill afford right now.
Joint Ventures rarely fail at launch. They fail eighteen months in.

Joint ventures rarely collapse at the signing table. They unravel later – in the governance gaps, cultural friction, and undefined exit terms that optimism at formation tends to overlook. With JV activity surging in 2026, understanding why matters more than ever.
AI investment is rising. Returns aren’t. It’s time for an honest conversation.

AI investment is rising sharply. Returns, for most organisations, are not. With only one in fifty AI initiatives delivering transformational value, the gap between expectation and reality is widening. The honest conversation about why is long overdue.
The life sciences M&A surge is accelerating. Is integration capability keeping up?

Life sciences M&A is booming, but the deals that deliver won’t be the fastest, they’ll be the best integrated. Here’s why due diligence needs to double as integration planning from day one.
Getting the Most From Your Consulting RFP: What to ask, what to check, and why it matters

The RFP stage sets the tone for the entire engagement. Getting it right, with clear scope, honest budgeting, and the right questions asked early, makes everything that follows considerably easier.
Change Fatigue is Real. Most transformation programmes make it worse.

Change fatigue builds quietly – layer by layer, programme by programme – until the people transformation depends on have nothing left to give. It’s not a people problem. It’s a programme design problem. And it’s largely avoidable.
When the Process is Fine – It’s the handoffs that are broken

Process optimisation can only deliver so much. When performance still disappoints despite the investment, the answer is usually found not in the processes themselves, but in the gaps between them.

